7NR5
Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E+ |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-05-10 |
Detector | DECTRIS EIGER R 1M |
Wavelength(s) | 1.54178 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 48.903, 70.937, 60.445 |
Unit cell angles | 90.00, 110.17, 90.00 |
Refinement procedure
Resolution | 30.070 - 1.766 |
R-factor | 0.1761 |
Rwork | 0.174 |
R-free | 0.22260 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.013 |
RMSD bond angle | 1.060 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | BUSTER |
Refinement software | BUSTER (2.11.7 (19-MAR-2020)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 44.310 | 1.800 |
High resolution limit [Å] | 1.766 | 1.766 |
Rmeas | 0.048 | 0.843 |
Number of reflections | 31797 | 1732 |
<I/σ(I)> | 10.1 | |
Completeness [%] | 83.4 | 94.3 |
Redundancy | 2.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.25M (NH4)2SO4 33% MPEG 2000 0.02M Mercaptoethanol 0.1M pH=7.2 HEPES/NaOH |